ストックスクリーナーアプリを入手
1.26
16.67%
0.18
アフターアワーズ：
1.21
-0.05
-3.97%
Codexis Inc (CDXS) 最新ニュース
Codexis, Inc. Hits New 52-Week Low at $0.96 Amid Financial Struggles - Markets Mojo
Clean the SkyClean Pharmaceutical Manufacturings - Trend Hunter
Codexis signs deal to produce siRNA for pharma partner - Investing.com
Why Did CDXS Stock Jump 7% Today? - Stocktwits
Codexis to Produce 50 Grams of siRNA Using ECO Synthesis Manufacturing Platform - geneonline.com
Codexis Agrees to Manufacture 50 Grams of siRNA Using its Proprietary Manufacturing Platform - Contract Pharma
Codexis (CDXS) Partners for siRNA Manufacturing in Cardiovascula - GuruFocus
Biotech Codexis tapped to scale RNA ingredient for heart drug research - Stock Titan
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - Yahoo Finance
Codexis at TD Cowen Conference: Strategic Shift to RNA Medicines - Investing.com
CDXS SEC FilingsCodexis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
CDXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CDXS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CEO of CODEXIS (CDXS) receives 993,000-share stock option grant - Stock Titan
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewswire
5,280-share RSU vesting sale at CDXS (NASDAQ: CDXS) - Stock Titan
Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Codexis (CDXS) Projected to Post Earnings on Thursday - MarketBeat
Is Codexis (NASDAQ:CDXS) Weighed On By Its Debt Load? - 富途牛牛
Codexis to Participate in TD Cowen 46th Annual Health Care Conference - The Manila Times
What makes Codexis Inc. stock attractive to growth fundsMarket Activity Report & Weekly High Return Forecasts - mfd.ru
What’s next for Codexis Inc. stock2025 Historical Comparison & Risk Managed Investment Entry Signals - mfd.ru
Positive Sentiment Still Eludes Codexis, Inc. (NASDAQ:CDXS) Following 29% Share Price Slump - simplywall.st
Macro Review: Does Codexis Inc offer margin of safetyGlobal Markets & Precise Buy Zone Identification - baoquankhu1.vn
Does Codexis Inc. stock trade at a discount to peersWeekly Investment Summary & Free Growth Oriented Trading Recommendations - mfd.ru
Codexis (CDXS) Achieves ISO 9001:2015 Certification - GuruFocus
Codexis Inc. Achieves ISO 9001:2015 Certification for Quality Management Excellence - Quiver Quantitative
What Codexis’ new ISO 9001 status means for enzyme buyers - Stock Titan
Analysts Expect Breakeven For Codexis, Inc. (NASDAQ:CDXS) Before Long - Yahoo Finance
RSI Check: What makes Codexis Inc stock attractive todayQuarterly Trade Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Biofuel Enzymes Market Set to Soar: Innovations Driving - openPR.com
Aberdeen Group plc Expands Stake in Codexis Inc with Significant Share Acquisition - GuruFocus
MACD Signal: Will Codexis Inc benefit from rising consumer demandMarket Performance Recap & Daily Price Action Insights - baoquankhu1.vn
Moving Averages: What are Codexis Incs recent SEC filings showingQuarterly Trade Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug PreEarnings: What is DYCQRs book value per shareWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Dividend Watch: Is Codexis Inc. stock vulnerable to regulatory risks2025 Sector Review & Daily Momentum Trading Reports - Bộ Nội Vụ
Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing - Contract Pharma
How Codexis Inc. stock reacts to Fed rate cutsShare Buyback & Smart Swing Trading Alerts - ulpravda.ru
Codexis CSO Stefan Lutz sells $7949 in shares By Investing.com - Investing.com Nigeria
Codexis CSO Stefan Lutz sells $7949 in shares - Investing.com
Is Codexis Inc. stock safe for conservative investorsJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Codexis (CDXS) Partners with Axolabs for Innovative RNA Manufact - GuruFocus
New partnership tests greener way to mass-produce RNA medicines - Stock Titan
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - Yahoo Finance
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Codexis strengthens board with biotech veteran Arthur Levin - MSN
Will Codexis Inc. stock benefit from green energy trendsJuly 2025 Levels & Free Weekly Watchlist of Top Performers - DonanımHaber
Opaleye Management Inc. Reduces Stake in Codexis Inc. - GuruFocus
How Codexis Inc. stock reacts to job market dataPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Opaleye management sells Codexis (CDXS) shares worth $877,846 By Investing.com - Investing.com Nigeria
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):